PATIENTS WITH HEPATIC BREAST CANCER METASTASES DEMONSTRATE HIGHLY SPECIFIC PROFILES OF MATRIX METALLOPROTEINASES MMP-2 AND MMP-9 AFTER SIRT TREATMENT AS COMPARED TO OTHER PRIMARY AND
Tìm thấy 10,000 tài liệu liên quan tới tiêu đề "Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metall...":
METFORMIN USE AND ITS EFFECT ON SURVIVAL IN DIABETIC PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
Previous population-based studies have demonstrated an association between metformin use and improved survival among diabetic patients with cancer. We sought to analyze the effects of diabetes and its treatment in terms of the survival of patients with lung cancer.
9 Đọc thêm
A SUPPRESSIVE ROLE OF GUANINE NUCLEOTIDEBINDING PROTEIN SUBUNIT BETA-4 INHIBITED BY DNA METHYLATION IN THE GROWTH OF ANTIESTROGEN RESISTANT BREAST CANCER CELLS
Breast cancer is the most common malignancy in women worldwide. Although the endocrine therapy that targets estrogen receptor α (ERα) signaling has been well established as an effective adjuvant treatment for patients with ERα-positive breast cancers, long-term exposure may eventually lead to the de[r]
CHAPTER 096 PARANEOPLASTIC SYNDROMES ENDOCRINOLOGICHEMATOLOGIC PART 8
etiology of thrombocytosis has not been established in most cases. Patients with thrombocytosis are nearly all asymptomatic. Thrombocytosis is not clearly linked to thrombosis in patients with cancer. Thrombocytosis is present in 40% of pati[r]
5 Đọc thêm
SOLITARY METASTASIS TO A SUPERIOR MEDIASTINAL LYMPH NODE AFTER DISTAL GASTRECTOMY FOR GASTRIC CANCER: A CASE REPORT
Mediastinal lymph node metastases occasionally occur in patients of advanced gastric cancer of the cardia with esophageal invasion, but they rarely occur in patients with gastric cancer of other sites.
Optitrain: A randomised controlled exercise trial for women with breast cancer undergoing chemotherapy
Women with breast cancer undergoing chemotherapy suffer from a range of detrimental disease and treatment related side-effects. Exercise has shown to be able to counter some of these side-effects and improve physical function as well as quality of life.
Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection
The purpose of this retrospective study was to determine whether RFA could provide an alternative treatment modality for selected patients who are not candidates for hepatic resection.
EVOLUTIONARY ASPECTS OF NON-METASTATIC BREAST CANCER AFTER PRIMARY TREATMENT IN A SUB-SAHARAN AFRICAN SETTING: A 16-YEAR RETROSPECTIVE REVIEW AT THE DOUALA GENERAL HOSPITAL, CAMEROON
Breast cancer has a high case fatality rate in sub-Saharan Africa, and this is chiefly because of late detection and inadequate treatment resources. Progressive renovations in diagnostic and management modalities of non-metastatic breast cancer (NMBC) have been noted in the region but there is pauci[r]
GRP78 EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS IS A NEW PREDICTIVE MARKER FOR THE BENEFIT OF TAXANES IN BREAST CANCER NEOADJUVANT TREATMENT
Breast cancer treatment is tailored to the specific cancer subtype. Often, systemic treatment is given prior to surgery. Chemotherapy induces significant endoplasmic reticulum (ER) stress-mediated cell death and upregulation of 78-kDa glucose-regulated protein (GRP78).
10 Đọc thêm
CRITICAL CARE OBSTETRICS PART 73 POTX
nancy can be attributed to trends toward delaying childbearing and the increased incidence of human immunodefi ciency syn-drome (HIV). The condition frequently presents as painless enlargement of the supradiaphragmatic lymph nodes, particu-larly supraclavicular, alo[r]
10 Đọc thêm
IMMUNOTHERAPY AND ASSOCIATED IMMUNERELATED ADVERSE EVENTS AT A LARGE UK CENTRE: A MIXED METHODS STUDY
The development and rapid uptake of immune checkpoint inhibitors (CPI) has changed the outlook for patients with cancer. However, CPIs have different adverse event (AE) profiles to other systemic therapies, and prompt AE management is essential to assure optimal outcomes.
11 Đọc thêm
QUESTIONS AND ANSWERS ABOUT BREAST CANCER BONE METASTASES & TREATMENT RELATED BONE LOSS PPT
and myeloma bone disease. This bisphosphonate drug is given by intravenous (IV) infusion every three to four weeks. Zoledronic acid (Zometa®), a stronger bisphosphonate, was approved by the FDA in 2002 for the treatment of cancers that spread to bone. Zoledronic a[r]
12 Đọc thêm
INDUCTION THERAPY WITH PACLITAXEL AND BEVACIZUMAB FOLLOWED BY SWITCH MAINTENANCE THERAPY WITH ERIBULIN IN JAPANESE PATIENTS WITH HER2-NEGATIVE METASTATIC BREAST CANCER: A MULTICENTER,
To examine the efficacy and safety of induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin (ISMT) in Japanese patients with HER2-negative metastatic breast cancer (MBC).
RISK OF SECOND PRIMARY CANCER IN MEN WITH BREAST CANCER DOCX
researchers throughout the nation, and the Public Health Insti-tute. It collects information about all cancers diagnosed in Cal-ifornia (except basal and squamous cell carcinoma of the skinand carcinoma in situ of the cervix). The database includesinformation on demograph[r]
7 Đọc thêm
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions
In metastatic breast cancer, the status of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), as well as the Ki-67 index sometimes change between primary and metastatic lesions. However, the change in expression levels of enhancer of zeste ho[r]
DEVELOPMENT OF THE BODY IMAGE SELF-RATING QUESTIONNAIRE FOR BREAST CANCER (BISQ-BC) FOR CHINESE MAINLAND PATIENTS
Body image is a complex post-treatment concern among female patients with breast cancer, and various tools have been developed and applied to measure this multifaceted issue. However, these available tools were developed in other countries and only a few have been modified into Chinese versions.
8 Đọc thêm
BÁO CÁO HÓA HỌC: " RESPONSIVENESS OF THE EQ-5D IN BREAST CANCER PATIENTS IN THEIR FIRST YEAR AFTER TREATMENT" PPT
differentiate between subgroups with no change andsmall changes in health. This argument also holds true forthe EQ-5D Index, which could not discriminate betweenthe 'no change' subgroup and the subgroup reporting amoderate-large deterioration in health (n = 23).A limitation of t[r]
7 Đọc thêm
THE EFFECTS OF LYMPH NODE STATUS ON PREDICTING OUTCOME IN ER+ /HER2- TAMOXIFEN TREATED BREAST CANCER PATIENTS USING GENE SIGNATURES
Lymph node (LN) status is the most important prognostic variable used to guide ER positive (+) breast cancer treatment. While a positive nodal status is traditionally associated with a poor prognosis, a subset of these patients respond well to treatment and achieve long-term survival.
11 Đọc thêm
Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer
B. Madhu Krishna 1 , Sanjib Chaudhary 1,2 , Dipti Ranjan Mishra 3 , Sanoj K. Naik 1 , S. Suklabaidya 4 , A. K. Adhya 5 and Sandip K. Mishra 1*
Abstract
Background: Breast cancer (BC) is highly heterogeneous with ~ 60 – 70% of estrogen receptor positive B[r]
Abstract
Background: Breast cancer (BC) is highly heterogeneous with ~ 60 – 70% of estrogen receptor positive B[r]
Evaluating the efficiency of endobronchial ultrasound for diagnosis of patients with suspected lung cancer
To evaluate the efficiency of endobronchial ultrasound for diagnosis of patients with suspected lung cancer. Subjects and methods: 82 patients with suspected primary lung cancer, treated at 103 Military Hospital and K3 Hospital located at Tan Trieu, Thanh Tri, Hanoi from January, 2013 to October, 20[r]
Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancerrelated fatigue - results of a three-
Cancer-related fatigue (CRF) and insomnia are major complaints in breast cancer survivors (BC). Aerobic training (AT), the standard therapy for CRF in BC, shows only minor to moderate treatment effects. Other evidence-based treatments include cognitive behavioral therapy, e.g., sleep education/restr[r]